These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10825335

  • 1. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide.
    Stabernack CR, Brown R, Laster MJ, Dudziak R, Eger EI.
    Anesth Analg; 2000 Jun; 90(6):1428-35. PubMed ID: 10825335
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo.
    Kharasch ED, Powers KM, Artru AA.
    Anesthesiology; 2002 Jan; 96(1):173-82. PubMed ID: 11753018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
    Mchaourab A, Arain SR, Ebert TJ.
    Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Important role of calcium chloride in preventing carbon monoxide generation during desflurane degradation with alkali hydroxide-free carbon dioxide absorbents.
    Ando T, Mori A, Ito R, Nishiwaki K.
    J Anesth; 2017 Dec; 31(6):911-914. PubMed ID: 28831619
    [Abstract] [Full Text] [Related]

  • 10. Only carbon dioxide absorbents free of both NaOH and KOH do not generate compound A during in vitro closed-system sevoflurane: evaluation of five absorbents.
    Versichelen LF, Bouche MP, Rolly G, Van Bocxlaer JF, Struys MM, De Leenheer AP, Mortier EP.
    Anesthesiology; 2001 Sep; 95(3):750-5. PubMed ID: 11575550
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. No compound a formation with Superia during minimal-flow sevoflurane anesthesia: a comparison with Sofnolime.
    Bouche MP, Versichelen LF, Struys MM, Van Bocxlaer JF, De Leenheer AP, Mortier EP, Rolly G.
    Anesth Analg; 2002 Dec; 95(6):1680-5, table of contents. PubMed ID: 12456439
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rehydration of desiccated Baralyme prevents carbon monoxide formation from desflurane in an anesthesia machine.
    Baxter PJ, Kharasch ED.
    Anesthesiology; 1997 May; 86(5):1061-5. PubMed ID: 9158355
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme and soda lime.
    Fang ZX, Kandel L, Laster MJ, Ionescu P, Eger EI.
    Anesth Analg; 1996 Apr; 82(4):775-81. PubMed ID: 8615497
    [Abstract] [Full Text] [Related]

  • 20. Compound A production from sevoflurane is not less when KOH-free absorbent is used in a closed-circuit lung model system.
    Versichelen L, Bouche MP, Struys M, Van Bocxlaer J, Mortier E, de Leenheer AP, Rolly G.
    Br J Anaesth; 2001 Mar; 86(3):345-8. PubMed ID: 11573522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.